Greenmark Biomedical Inc.
East Lansing, MI
- UEI
- C18FULMF7G73
- CAGE
- 7Q1M7
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 325 E Grand River Ave #314, East Lansing, MI 48823, USA
- Website
- greenmark.bio
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Regents Of The University Of Michigan | U24DE029462 | -$166,375 | |
| Regents Of The University Of Michigan | U24DE029462 | $326,755 |
Similar vendors
About the company
Greenmark Biomedical Inc. is a for-profit corporate entity registered in the System for Award Management (SAM) since August 2, 2016, with its primary address located in East Lansing, Michigan. The company focuses on innovative dental and oral health technologies, specializing in advanced research and development of nanomaterials and imaging technologies aimed at addressing dental caries and oral disease prevention. While specific details about the company's full organizational structure are not provided, their federal grant history indicates a strong commitment to developing cutting-edge solutions for dental health challenges.
The company has been awarded multiple federal grants from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program, totaling approximately $565,226 in recent awards. These grants support two primary research initiatives: first, developing nano-fluorapatite particles to restore non-cavitated carious lesions in enamel, with the goal of creating over-the-counter products that can halt dental caries progression; and second, creating an AI-assisted intraoral imaging system using targeted nanoparticle-enhanced fluorescent technology to improve caries detection and monitoring. Additionally, Greenmark Biomedical has collaborated with the University of Michigan through a sub-grant award focused on developing bioresorbable starch-based nanoparticles for delivering minerals and fluoride to early-stage dental lesions, with the ultimate aim of obtaining FDA 510(k) clearance and bringing transformative dental treatment products to market.
Quick answers
Is Greenmark Biomedical Inc. registered in SAM.gov?
Yes. Greenmark Biomedical Inc.'s SAM.gov registration is active through May 21, 2027.
What is Greenmark Biomedical Inc.'s most recent federal award?
Greenmark Biomedical Inc.'s most recent federal grant award is Restoration of non-cavitated carious lesions in enamel using nano-fluorapatite particles (R43DE035019), from National Institute of Dental and Craniofacial Research (NIH), on September 1, 2025.
On GovTribe
See Greenmark Biomedical Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors